WeVote
Log In

Bill

Bill

SB 562

AN ACT CONCERNING FUNDING FOR THE CONNECTICUT RARE DISEASE ADVISORY COUNCIL.

2025 Regular Session Introduced by Saud Anwar and 2 co-sponsors

Connecticut allocates state funding to establish and operate an advisory council addressing rare disease patient care, coordination, and policy gaps.

REF. TO JOINT COMM. ON Public Health
#diseases
0
WeVote Research Nonpartisan
Bill Summary · SB 562

Legislative bill overview

SB 562 allocates funding to establish and operate the Connecticut Rare Disease Advisory Council, a body designed to address policy gaps and improve outcomes for patients with rare diseases in the state. The bill provides financial resources to support the council's administrative operations, research coordination, and stakeholder engagement activities.

Why is this important

Rare diseases collectively affect millions of Americans but individually receive limited research attention and medical expertise. Dedicated funding for a state advisory council can improve care coordination, reduce diagnostic delays, and help patients navigate fragmented healthcare systems by centralizing information and advocacy efforts.

Potential points of contention

  • Fiscal impact and budget priorities: Opponents may question whether state funding is appropriate for this purpose versus federal mechanisms or private foundations already supporting rare disease work
  • Council scope and authority: Unclear what regulatory or advisory power the council will exercise, and whether it duplicates existing state health department functions or private organizations
  • Unspecified funding amount: The bill's language does not detail the actual appropriation level, making it difficult to assess cost-effectiveness or long-term sustainability

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.